Search Results for: RTN4

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel CGREF1 cell growth regulator with EF-hand domain 1
Novel CHMP6 charged multivesicular body protein 6
  • Budding and maturation of HIV virion
  • Macroautophagy
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • HCMV Late Events
  • Late endosomal microautophagy
  • Sealing of the nuclear envelope (NE) by ESCRT-III
  • Translation of Replicase and Assembly of the Replication Transcription Complex
  • Translation of Replicase and Assembly of the Replication Transcription Complex
Novel IPP intracisternal A particle-promoted polypeptide
Novel NRXN1 neurexin 1
  • Neurexins and neuroligins
  • Neurexins and neuroligins
  • Non-integrin membrane-ECM interactions
  • Neurexins and neuroligins
  • Neurexins and neuroligins
  • Calcium citrate
  • Calcium Phosphate
  • Calcium phosphate dihydrate
  • Pitt-Hopkins syndrome, including: Pitt-Hopkins syndrome; Pitt-Hopkins-like syndrome
Novel NSD1 nuclear receptor binding SET domain protein 1
  • PKMTs methylate histone lysines
  • Beckwith-Wiedemann syndrome
  • Sotos syndrome and Weaver syndrome
Novel PPP1R21 protein phosphatase 1 regulatory subunit 21
Novel STON1 stonin 1
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
BAIAP2 BAR/IMD domain containing adaptor protein 2
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • VEGFA-VEGFR2 Pathway
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
BCL2 BCL2 apoptosis regulator
  • Activation of BAD and translocation to mitochondria
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Interleukin-4 and Interleukin-13 signaling
  • The NLRP1 inflammasome
  • Estrogen-dependent gene expression
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Ibuprofen
  • Paclitaxel
  • Docetaxel
  • Rasagiline
  • Paclitaxel docosahexaenoic acid
  • Apoptone
  • Glycine betaine
  • Eribulin
  • Dexibuprofen
  • Isosorbide
  • Venetoclax
  • Obatoclax
  • Navitoclax
  • Choriocarcinoma
  • Gastric cancer
  • Chronic lymphocytic leukemia (CLL)
  • Small cell lung cancer
  • Kaposi's sarcoma
  • Nasopharyngeal cancer
  • Cervical cancer
BCL2L1 BCL2 like 1
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Interleukin-4 and Interleukin-13 signaling
  • The NLRP1 inflammasome
  • RAS processing
  • STAT5 activation downstream of FLT3 ITD mutants
  • 4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID
  • Isosorbide
  • Gossypol
BDKRB1 bradykinin receptor B1
  • Peptide ligand-binding receptors
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Ramipril
  • Captopril
  • Zinc
  • Enalaprilat
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
CCR4 C-C motif chemokine receptor 4
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
  • Mogamulizumab
  • FLX475
CERT1 ceramide transporter 1
CHRM4 cholinergic receptor muscarinic 4
  • Muscarinic acetylcholine receptors
  • G alpha (i) signalling events
  • Ziprasidone
  • Amitriptyline
  • Olanzapine
  • Metixene
  • Terfenadine
  • Clozapine
  • Doxylamine
  • Trihexyphenidyl
  • Procyclidine
  • Loxapine
  • Carbamoylcholine
  • Hyoscyamine
  • Meperidine
  • Imipramine
  • Darifenacin
  • Nortriptyline
  • Amoxapine
  • Cinnarizine
  • Atropine
  • Nicardipine
  • Paroxetine
  • Homatropine methylbromide
  • Trimipramine
  • Scopolamine
  • Benzquinamide
  • Propiomazine
  • Tropicamide
  • Brompheniramine
  • Maprotiline
  • Methantheline
  • Bethanechol
  • Tolterodine
  • Promethazine
  • Pilocarpine
  • Doxepin
  • Desipramine
  • Ketamine
  • Quetiapine
  • Aripiprazole
  • Chlorprothixene
  • Methotrimeprazine
  • Tiotropium
  • Solifenacin
  • Isopropamide
  • Acetylcholine
  • ALKS 27
  • Fesoterodine
  • Hexocyclium
  • Aclidinium
  • Umeclidinium
  • Trimebutine
  • Dosulepin
  • Etoperidone
  • Homatropine
  • Thonzylamine
  • Revefenacin
  • Propiverine
  • Rociverine
  • Aripiprazole lauroxil
CLN8 CLN8 transmembrane ER and ERGIC protein
  • Neuronal ceroid lipofuscinosis, including: Infantile Neuronal Ceroid Lipofuscinosis (INCL)/ Santavuori-Haltia Disease (CLN1); Late-Infantile Neuronal Ceroid Lipofuscinosis (LINCL)/ Jansky-Bielschowsky Disease (CLN2); Juvenile Neuronal Ceroid Lipofuscinosis (JNCL)/Batten Disease/ Spielmeyer-Vogt Disease (CLN3); Adult Neuronal Ceroid Lipofuscinosis (ANCL)/ Kufs Disease (CLN4); LINCL variant (CLN5, CLN6, CLN7, CLN8); Batten Disease variant (CLN9); Congenital NCL (CLN10)
  • Progressive myoclonic epilepsy (PME), including: Lafora disease (LBD); Unverricht-Lundborg disease (ULD); Neuronal ceroid lipofuscinoses (NCL); Type I sialidosis; Action myoclonus-renal failure syndrome (AMRF); Type III Gaucher disease (GD)
CNTNAP1 contactin associated protein 1
  • Neurofascin interactions
CRMP1 collapsin response mediator protein 1
  • CRMPs in Sema3A signaling
CYSLTR2 cysteinyl leukotriene receptor 2
  • Glucagon signaling in metabolic regulation
  • Leukotriene receptors
  • G alpha (q) signalling events
  • G alpha (s) signalling events
  • Glucagon-type ligand receptors
  • ADORA2B mediated anti-inflammatory cytokines production
  • LTC4-CYSLTR mediated IL4 production
  • Nedocromil
  • Leukotriene C4
  • Leukotriene D4
DRD2 dopamine receptor D2
  • Dopamine receptors
  • Amphetamine
  • Ziprasidone
  • Cabergoline
  • Ropinirole
  • Olanzapine
  • Clozapine
  • Thiethylperazine
  • Sulpiride
  • Loxapine
  • Remoxipride
  • Pramipexole
  • Promazine
  • Prochlorperazine
  • Droperidol
  • Imipramine
  • Chlorpromazine
  • Buspirone
  • Haloperidol
  • Triflupromazine
  • Nortriptyline
  • Amoxapine
  • Lamotrigine
  • Cinnarizine
  • Lisuride
  • Fluphenazine
  • Thioridazine
  • Ergotamine
  • Apomorphine
  • Paroxetine
  • Trimipramine
  • Risperidone
  • Propiomazine
  • Minaprine
  • Trifluoperazine
  • Perphenazine
  • Flupentixol
  • Amantadine
  • Mesoridazine
  • Maprotiline
  • Dopamine
  • Carphenazine
  • Memantine
  • Ergoloid mesylate
  • Acetophenazine
  • Promethazine
  • Pimozide
  • Desipramine
  • Escitalopram
  • Domperidone
  • Pergolide
  • Bromocriptine
  • Ketamine
  • Quetiapine
  • Metoclopramide
  • Levodopa
  • Aripiprazole
  • Chlorprothixene
  • Paliperidone
  • Yohimbine
  • Methotrimeprazine
  • Alizapride
  • Rolicyclidine
  • Acepromazine
  • Molindone
  • Pipotiazine
  • Thioproperazine
  • Thiothixene
  • Zuclopenthixol
  • Aniracetam
  • Fluspirilene
  • Tetrabenazine
  • Brasofensine
  • Bifeprunox
  • Bicifadine
  • Itopride
  • Iloperidone
  • Rotigotine
  • Pimavanserin
  • BL-1020
  • ACP-104
  • Amitifadine
  • Cariprazine
  • Lumateperone
  • YKP-1358
  • Sertindole
  • Mianserin
  • Asenapine
  • Ocaperidone
  • Amisulpride
  • Sarizotan
  • Sumanirole
  • Lurasidone
  • Perospirone
  • Bromopride
  • Quinagolide
  • Brexpiprazole
  • Etoperidone
  • AS-8112
  • Blonanserin
  • Melperone
  • Zotepine
  • Pipamperone
  • Dihydro-alpha-ergocryptine
  • Epicriptine
  • Pardoprunox
  • Tetrahydropalmatine
  • Piribedil
  • Raclopride
  • JNJ-37822681
  • Tiapride
  • Dihydroergocristine
  • Aripiprazole lauroxil
ERBB2 erb-b2 receptor tyrosine kinase 2
  • Signaling by ERBB2
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PLCG1 events in ERBB2 signaling
  • PIP3 activates AKT signaling
  • GRB7 events in ERBB2 signaling
  • Downregulation of ERBB2:ERBB3 signaling
  • GRB2 events in ERBB2 signaling
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Sema4D induced cell migration and growth-cone collapse
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Downregulation of ERBB2 signaling
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • Constitutive Signaling by Overexpressed ERBB2
  • Drug-mediated inhibition of ERBB2 signaling
  • Signaling by ERBB2 KD Mutants
  • Resistance of ERBB2 KD mutants to trastuzumab
  • Resistance of ERBB2 KD mutants to sapitinib
  • Resistance of ERBB2 KD mutants to tesevatinib
  • Resistance of ERBB2 KD mutants to neratinib
  • Resistance of ERBB2 KD mutants to osimertinib
  • Resistance of ERBB2 KD mutants to afatinib
  • Resistance of ERBB2 KD mutants to AEE788
  • Resistance of ERBB2 KD mutants to lapatinib
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Drug resistance in ERBB2 TMD/JMD mutants
  • Trastuzumab
  • Lapatinib
  • IGN311
  • Trastuzumab emtansine
  • Varlitinib
  • AV-412
  • Pertuzumab
  • Afatinib
  • Tucatinib
  • Tesevatinib
  • Fostamatinib
  • Brigatinib
  • Margetuximab
  • Zanubrutinib
  • Choriocarcinoma
  • Pancreatic cancer
  • Gastric cancer
  • Bladder cancer
  • Endometrial Cancer
  • Ovarian cancer
  • Cholangiocarcinoma
  • Breast cancer
  • Cervical cancer

Page 1 out of 3 pages